Elekta Impac Software Selected to Present at Electronic Health Records Symposium

Oct 05, 2009, 09:00 ET from Elekta

SAN FRANCISCO, Oct. 5 /PRNewswire/ -- Elekta Impac Software has been selected to demonstrate at the 2009 American Society of Clinical Oncology (ASCO) Electronic Health Records (EHR) Symposium: Harnessing the EHR, From Incentives to Sustainability, October 6-7, in San Francisco, California. Open to the entire cancer care team, including oncologists, administrators and nurses, the forum will arm health care providers with the knowledge to successfully select and implement an oncology-specific EHR in their practice.

One of eight vendors chosen, Elekta Impac Software will conduct demonstrations of its integrated oncology EHR, MOSAIQ®. Designed for use in the medical and radiation oncology environment, MOSAIQ has helped practices - across the globe, both large and small - reduce costs, enhance efficiency and strengthen business performance. In addition to the demonstrations, participants will have an opportunity to test and experiment MOSAIQ, including its capacity to:

  • streamline chemotherapy ordering and administration,
  • improve clinical documentation,
  • increase reimbursement,
  • connect and communicate with other departments, and
  • support quality initiatives.

"Not all electronic health records are the same, and we're looking forward to helping participants gain not only a better understanding of MOSAIQ, but the role Elekta will play in the future of health care IT," says Donna Getreuer, Director of Medical Oncology Business Marketing for Elekta Impac Software.

As part of the economic stimulus bill, the federal government allocated $19.2 billion dollars in incentives to encourage the adoption of EHRs among physicians and hospitals. This portion of this bill is entitled the Health Information Technology for Economic and Clinical Health Act, or HITECH Act, and strongly encourages the health care industry to go paperless by 2015.

Sima Aziz, Elekta Impac Software's Business Line Manager for Medical Oncology, notes, "We commend the governments' goal of improving the quality of patient care, and believe that building a strong IT infrastructure within our health care system will expedite the realization of this goal. We are pleased the stimulus has provisions to help physicians and hospitals deliver the best possible patient care."

ASCOs EHR Symposium will take place: Tuesday, October 6 from 7 a.m. - 4:15 p.m. and Wednesday, October 7 from 7 a.m. - 12:20 p.m.

For additional information, visit www.asco.org/ehrsymposium. For the latest MOSAIQ news, stop by table #3 at the symposium, or visit www.impac.com/mosaiq.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

About ASCO

The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.